Quick Answer
ANAPTYSBIO, INC reported Stockholders Equity of $37.21 million for fiscal year 2025.
ANAPTYSBIO, INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $37.21M | -47.5% |
| 2024 | $70.87M | -19.6% |
| 2023 | $88.10M | -66.4% |
| 2022 | $262.10M | -26.5% |
| 2021 | $356.43M | -10.2% |
| 2020 | $396.73M | -2.0% |
| 2019 | $405.01M | -16.7% |
| 2018 | $486.37M | +58.1% |
| 2017 | $307.58M | +904.2% |
| 2016 | -$38.25M | -8.7% |
| 2015 | -$35.18M | -14.1% |
| 2014 | -$30.84M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$29.42M | -134.9% | +34.2% |
| June 30, 2025 | -$44.73M | -552.8% | -231.5% |
| March 31, 2025 | $34.02M | -28.8% | -52.0% |
| December 31, 2024 | $70.87M | -19.6% | -16.0% |
| September 30, 2024 | $84.37M | -29.9% | +754.0% |
| June 30, 2024 | $9.88M | -93.3% | -79.3% |
| March 31, 2024 | $47.78M | -75.0% | -45.8% |
| December 31, 2023 | $88.10M | -66.4% | -26.8% |
- ANAPTYSBIO, INC showed a decrease of -47.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2014–2025 period, ANAPTYSBIO, INC’s stockholders equity has grown by 220.7% (from -$30.84 million to $37.21 million).
- The most recent figure is from ANAPTYSBIO, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: